These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 9466531)

  • 1. Do in vitro susceptibility data predict the microbiologic response to amphotericin B? Results of a prospective study of patients with Candida fungemia.
    Nguyen MH; Clancy CJ; Yu VL; Yu YC; Morris AJ; Snydman DR; Sutton DA; Rinaldi MG
    J Infect Dis; 1998 Feb; 177(2):425-30. PubMed ID: 9466531
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of amphotericin B interpretive breakpoints for Candida bloodstream isolates by correlation with therapeutic outcome.
    Park BJ; Arthington-Skaggs BA; Hajjeh RA; Iqbal N; Ciblak MA; Lee-Yang W; Hairston MD; Phelan M; Plikaytis BD; Sofair AN; Harrison LH; Fridkin SK; Warnock DW
    Antimicrob Agents Chemother; 2006 Apr; 50(4):1287-92. PubMed ID: 16569842
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antifungal susceptibility testing of isolates from a randomized, multicenter trial of fluconazole versus amphotericin B as treatment of nonneutropenic patients with candidemia. NIAID Mycoses Study Group and the Candidemia Study Group.
    Rex JH; Pfaller MA; Barry AL; Nelson PW; Webb CD
    Antimicrob Agents Chemother; 1995 Jan; 39(1):40-4. PubMed ID: 7695326
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correlation between in vitro susceptibility determined by E test and response to therapy with amphotericin B: results from a multicenter prospective study of candidemia.
    Clancy CJ; Nguyen MH
    Antimicrob Agents Chemother; 1999 May; 43(5):1289-90. PubMed ID: 10223955
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nosocomial fungemia due to amphotericin B-resistant Candida spp. in three pediatric patients after previous neurosurgery for brain tumors.
    Kovacicova G; Hanzen J; Pisarcikova M; Sejnova D; Horn J; Babela R; Svetlansky I; Lovaszova M; Gogova M; Krcmery V
    J Infect Chemother; 2001 Mar; 7(1):45-8. PubMed ID: 11406756
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antifungal susceptibility testing and the correlation with clinical outcome in neonatal candidemia.
    Huang YC; Kao HT; Lin TY; Kuo AJ
    Am J Perinatol; 2001 May; 18(3):141-6. PubMed ID: 11414524
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improved detection of amphotericin B-resistant isolates of Candida lusitaniae by Etest.
    Peyron F; Favel A; Michel-Nguyen A; Gilly M; Regli P; Bolmström A
    J Clin Microbiol; 2001 Jan; 39(1):339-42. PubMed ID: 11136795
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Minimum fungicidal concentrations of amphotericin B for bloodstream Candida species.
    Cantón E; Pemán J; Viudes A; Quindós G; Gobernado M; Espinel-Ingroff A
    Diagn Microbiol Infect Dis; 2003 Mar; 45(3):203-6. PubMed ID: 12663162
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transient fungemia caused by an amphotericin B-resistant isolate of Candida haemulonii.
    Rodero L; Cuenca-Estrella M; Córdoba S; Cahn P; Davel G; Kaufman S; Guelfand L; Rodríguez-Tudela JL
    J Clin Microbiol; 2002 Jun; 40(6):2266-9. PubMed ID: 12037106
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Candidemia in a tertiary care cancer center: in vitro susceptibility and its association with outcome of initial antifungal therapy.
    Antoniadou A; Torres HA; Lewis RE; Thornby J; Bodey GP; Tarrand JP; Han XY; Rolston KV; Safdar A; Raad II; Kontoyiannis DP
    Medicine (Baltimore); 2003 Sep; 82(5):309-21. PubMed ID: 14530780
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Survey of amphotericin B susceptibility of Candida clinical isolates determined by Etest.
    Chiu YS; Chang SC; Hsueh PR; Wang JL; Sun HY; Chen YC
    J Microbiol Immunol Infect; 2006 Aug; 39(4):335-41. PubMed ID: 16926981
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Caspofungin in combination with amphotericin B against Candida glabrata.
    Barchiesi F; Spreghini E; Fothergill AW; Arzeni D; Greganti G; Giannini D; Rinaldi MG; Scalise G
    Antimicrob Agents Chemother; 2005 Jun; 49(6):2546-9. PubMed ID: 15917570
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Change in colony morphology of Candida lusitaniae in association with development of amphotericin B resistance.
    McClenny NB; Fei H; Baron EJ; Gales AC; Houston A; Hollis RJ; Pfaller MA
    Antimicrob Agents Chemother; 2002 May; 46(5):1325-8. PubMed ID: 11959563
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Community-acquired fungemia due to a multiple-azole-resistant strain of Candida tropicalis.
    Jandourek A; Brown P; Vazquez JA
    Clin Infect Dis; 1999 Dec; 29(6):1583-4. PubMed ID: 10585825
    [No Abstract]   [Full Text] [Related]  

  • 15. Activity of voriconazole, itraconazole, fluconazole and amphotericin B in vitro against 1763 yeasts from 472 patients in the voriconazole phase III clinical studies.
    Johnson E; Espinel-Ingroff A; Szekely A; Hockey H; Troke P
    Int J Antimicrob Agents; 2008 Dec; 32(6):511-4. PubMed ID: 18790613
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tolerance to amphotericin B in clinical isolates of Candida tropicalis.
    Barchiesi F; Maracci M; Baldassarri I; Spreghini E; Giannini D; Scalise G
    Diagn Microbiol Infect Dis; 2004 Nov; 50(3):179-85. PubMed ID: 15541603
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationship between susceptibility of Candida spp. isolates to amphotericin B and death or survival of patients with candidemia episodes.
    Alves SH; Boff E; Pozzatti P; Scheid LA; de Loreto E; Ottoneli Oliveira LT; Aquino V; Severo LC; Santurio JM
    Mycopathologia; 2009 Feb; 167(2):65-71. PubMed ID: 18819017
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Amphotericin B-resistant yeast infection in severely immunocompromised patients.
    Powderly WG; Kobayashi GS; Herzig GP; Medoff G
    Am J Med; 1988 May; 84(5):826-32. PubMed ID: 3284339
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Distribution and antifungal susceptibility of Candida species causing candidemia from 1996 to 1999.
    Cheng MF; Yu KW; Tang RB; Fan YH; Yang YL; Hsieh KS; Ho M; Lo HJ
    Diagn Microbiol Infect Dis; 2004 Jan; 48(1):33-7. PubMed ID: 14761719
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro antifungal susceptibility testing of Candida blood isolates and evaluation of the E-test method.
    Lu JJ; Lee SY; Chiueh TS
    J Microbiol Immunol Infect; 2004 Dec; 37(6):335-42. PubMed ID: 15599465
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.